Elevated expression of urotensin II and its receptor in diabetic cardiomyopathy

被引:25
作者
Dai, Hong-Yan [1 ,2 ,3 ]
Guo, Xin-Gui [3 ]
Ge, Zhi-Ming [1 ,2 ]
Li, Zhen-Hua [1 ,2 ]
Yu, Xiao-Jing [4 ]
Tang, Meng-Xiong [1 ,2 ]
Zhang, Yun [1 ,2 ]
机构
[1] Shandong Univ, Qilu Hosp, Chinese Minist Educ, Key Lab Cardiovasc Remodling & Funct Res, Jinan 250100, Shandong, Peoples R China
[2] Shandong Univ, Qilu Hosp, Chinese Minist Publ Hlth, Jinan 250100, Shandong, Peoples R China
[3] Qingdaos Municipal Hosp, Dept Cardiol, Qingdao, Shandong, Peoples R China
[4] Shandong Univ, Qilu Hosp, Dept Dermatol, Jinan 250100, Shandong, Peoples R China
关键词
urotensin II; diabetic cardiomyopathy; cardiac remodeling;
D O I
10.1016/j.jdiacomp.2006.10.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Urotensin II (UII) is a somatostatin-like peptide recently identified to have several cardiovascular effects, including potent vasoactive, cardiac inotropic and chronotropic properties. Our aim was to determine the degree of expression of UII and UII receptor (UT) in the myocardium of rats with streptozotocin (STZ)-induced diabetes. Methods: Real-time polymerase chain reaction, Western blot, and immunohistochemistry were used to determine the degree of expression and location of UII and UT in the myocardium of STZ-induced diabetic rats. Results: UII and UT expression were significantly enhanced in the myocardium of rats with diabetes compared with healthy controls on both messenger RNA and protein levels. Both UII and UT protein expression were mainly concentrated in the cardiomyocytes, endothelial cells, cardiac fibroblasts, and smooth muscle cells of diabetic cardiomyopathy (DCM). Conclusions: Our results suggest a possible role for the UII/UT system in the pathophysiology of DCM. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:137 / 143
页数:7
相关论文
共 38 条
[1]   Molecular and cellular basis of the aetiology and management of diabetic cardiomyopathy: A short review [J].
Adeghate, E .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2004, 261 (1-2) :187-191
[2]   Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14 [J].
Ames, RS ;
Sarau, HM ;
Chambers, JK ;
Willette, RN ;
Alyar, NV ;
Romanic, AM ;
Louden, CS ;
Foley, JJ ;
Sauermelch, CF ;
Coatney, RW ;
Ao, ZH ;
Disa, J ;
Holmes, SD ;
Stadel, JM ;
Martin, JD ;
Liu, WS ;
Glover, GI ;
Wilson, S ;
McNulty, DE ;
Ellis, CE ;
Elshourbagy, NA ;
Shabon, U ;
Trill, JJ ;
Hay, DWP ;
Ohlstein, EH ;
Bergsma, DJ ;
Douglas, SA .
NATURE, 1999, 401 (6750) :282-286
[3]   Diabetes and idiopathic cardiomyopathy - A nationwide case-control study [J].
Bertoni, AG ;
Tsai, A ;
Kasper, EK ;
Brancati, FL .
DIABETES CARE, 2003, 26 (10) :2791-2795
[4]   Urotensin II evokes potent vasoconstriction in humans in vivo [J].
Böhm, F ;
Pernow, J .
BRITISH JOURNAL OF PHARMACOLOGY, 2002, 135 (01) :25-27
[5]   Urotensin-II blockade with SB-611812 attenuates cardiac dysfunction in a rat model of coronary artery ligation [J].
Bousette, Nicolas ;
Hu, Fu ;
Ohlstein, Eliot H. ;
Dhanak, Dashyant ;
Douglas, Stephen A. ;
Giaid, Adel .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2006, 41 (02) :285-295
[6]   Diabetes-induced myocardial structural changes: Role of endothelin-1 and its receptors [J].
Chen, S ;
Evans, T ;
Mukherjee, K ;
Karmazyn, M ;
Chakrabarti, S .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2000, 32 (09) :1621-1629
[7]   The urotensin-II receptor antagonist palosuran improves pancreatic and renal function in diabetic rats [J].
Clozel, M ;
Hess, P ;
Qiu, CB ;
Ding, SS ;
Rey, M .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 316 (03) :1115-1121
[8]   Congestive heart failure and expression of myocardial urotensin II [J].
Douglas, SA ;
Tayara, L ;
Ohlstein, EH ;
Halawa, N ;
Giaid, A .
LANCET, 2002, 359 (9322) :1990-1997
[9]   Differential vasoconstrictor activity of human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey [J].
Douglas, SA ;
Sulpizio, AC ;
Piercy, V ;
Sarau, HM ;
Ames, RS ;
Aiyar, NV ;
Ohlstein, EH ;
Willette, RN .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 131 (07) :1262-1274
[10]   Myocyte death in streptozotocin-induced diabetes in rats is angiotensin II-dependent [J].
Fiordaliso, F ;
Li, BS ;
Latini, R ;
Sonnenblick, EH ;
Anversa, P ;
Leri, A ;
Kajstura, J .
LABORATORY INVESTIGATION, 2000, 80 (04) :513-527